American Soil Technologies Inc (SOYL) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
9018 BALBOA BLVD, #558 NORTHRIDGE, CA 91304 |
| State of Incorp. | |
| Fiscal Year End | September 30 |
| Industry (SIC) | 287 - Agricultural Chemicals (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2015 | 9/30/2014 | 9/30/2013 | 9/30/2012 | |||
|---|---|---|---|---|---|---|
| ASSETS | ||||||
| Current Assets | ||||||
| Cash, cash equivalents, and short-term investments | 3 | 3 | 4 | |||
| Cash and cash equivalents | 3 | 3 | 4 | |||
| Receivables | 1 | (33) | 0 | |||
| Inventory, net of allowances, customer advances and progress billings | 5 | 5 | ||||
| Inventory | 5 | 5 | ||||
| Prepaid expense and other current assets | ✕ | ✕ | ✕ | 1 | ||
| Other undisclosed current assets | 1 | 36 | ||||
| Total current assets: | 5 | 10 | 11 | |||
| Noncurrent Assets | ||||||
| Property, plant and equipment | 0 | 0 | ||||
| Intangible assets, net (including goodwill) | 10 | 52 | ||||
| Intangible assets, net (excluding goodwill) | 10 | 52 | ||||
| Total noncurrent assets: | 10 | 52 | ||||
| Other undisclosed assets | ||||||
| TOTAL ASSETS: | 5 | 21 | 63 | |||
| LIABILITIES AND EQUITY | ||||||
| Liabilities | ||||||
| Current Liabilities | ||||||
| Accounts payable and accrued liabilities | 4,935 | 4,728 | 6,427 | |||
| Employee-related liabilities | 2,041 | |||||
| Accounts payable | 1,401 | 1,468 | 1,678 | |||
| Accrued liabilities | 3,533 | 3,260 | 2,709 | |||
| Debt | 1,748 | 1,945 | ||||
| Estimated litigation liability | 604 | 604 | ||||
| Due to related parties | 1,098 | 252 | ||||
| Other undisclosed current liabilities | 173 | |||||
| Total current liabilities: | 7,780 | 7,277 | 7,456 | |||
| Noncurrent Liabilities | ||||||
| Other undisclosed liabilities | 600 | |||||
| Total liabilities: | 7,780 | 7,877 | 7,456 | |||
| Equity | ||||||
| Equity, attributable to parent | (7,775) | (7,856) | (7,393) | |||
| Preferred stock | 1,382 | 1,382 | 1,382 | |||
| Common stock | 68 | 68 | 68 | |||
| Additional paid in capital | 19,832 | 19,832 | 19,832 | |||
| Accumulated deficit | (29,057) | (29,137) | (28,675) | |||
| Total equity: | (7,775) | (7,856) | (7,393) | |||
| TOTAL LIABILITIES AND EQUITY: | 5 | 21 | 63 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2015 | 9/30/2014 | 9/30/2013 | 9/30/2012 | ||
|---|---|---|---|---|---|
| Revenues | 30 | 64 | 71 | ||
| Cost of revenue (Cost of Goods and Services Sold) | (9) | (24) | (26) | ||
| Gross profit: | 20 | 40 | 45 | ||
| Operating expenses | (497) | (539) | (583) | ||
| Operating loss: | (477) | (499) | (538) | ||
| Interest and debt expense | (714) | (247) | (27) | ||
| Loss from continuing operations before equity method investments, income taxes: | (1,190) | (746) | (565) | ||
| Other undisclosed income (loss) from continuing operations before income taxes | 1,272 | 284 | (78) | ||
| Income (loss) from continuing operations before income taxes: | 82 | (461) | (643) | ||
| Income tax expense | (1) | (1) | (1) | ||
| Income (loss) from continuing operations: | 81 | (462) | (644) | ||
| Income (loss) before gain (loss) on sale of properties: | 81 | (462) | (644) | ||
| Net income (loss) available to common stockholders, diluted: | 81 | (462) | (644) | ||
Comprehensive Income ($ in thousands)
| 9/30/2015 | 9/30/2014 | 9/30/2013 | 9/30/2012 | ||
|---|---|---|---|---|---|
| Net income (loss): | 81 | (462) | (644) | ||
| Comprehensive income (loss), net of tax, attributable to parent: | 81 | (462) | (644) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.